Loading...
The Safety and Efficacy of the Repeated PRRT with [(90)Y]Y/[(177)Lu]Lu-DOTATATE in Patients with NET
PURPOSE: The peptide receptor radionuclide therapy (PRRT) is a treatment option for patients with disseminated, inoperable G1 and G2 neuroendocrine tumours (NETs). The study aims to evaluate the safety, efficacy, and progression-free survival (PFS) of patients after retreatment (R-PRRT) and re-retre...
Na minha lista:
| Udgivet i: | Int J Endocrinol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7847334/ https://ncbi.nlm.nih.gov/pubmed/33552155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6615511 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|